Setmelanotide

Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.protein_peptidePhase 3Active

64/ 100

Provisional rating · Methodology v0.2

Rating breakdown

9 Active assets in the Acquired Hypothalamic Obesity cohort.

Asset / Sponsor	Phase	Rating
Exenatide University Hospital, Bordeaux	Phase 3	BB
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R,R))- Novartis	Phase 4	BB
Tirzepatide Grace Kim	Phase 4	BB
Metformin The Hospital for Sick Children	Phase 2	B
lb54640 Rhythm Pharmaceuticals, Inc.	Phase 2	B